[Hepatitis B vaccine and demyelinating diseases: debate and disinformation].
Pol
Stanislas
S
D000293:Adolescent; D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000517:prevention & control; D015984:Causality; D002648:Child; D003430:Cross-Sectional Studies; D003711:Demyelinating Diseases / Q000453:epidemiology / Q000209:etiology*; D004827:Epilepsy / Q000453:epidemiology / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006306:Health Surveys; D006509:Hepatitis B / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D006510:Hepatitis B Antibodies / Q000097:blood; D017325:Hepatitis B Vaccines / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008103:Liver Cirrhosis / Q000453:epidemiology / Q000517:prevention & control; D008113:Liver Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D011247:Pregnancy; D012307:Risk Factors; D016896:Treatment Outcome
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines